Lpath, Inc. Provides Update on Plans for iSONEP Option
10/9/2013 9:00:53 AM
More...
|
Lpath, Inc. Awarded National Institutes of Health (NIH) SBIR Grant for Lpathomab
9/23/2013 9:56:06 AM
More...
|
Lpath, Inc. to Present at the 2013 JMP Healthcare Conference on July 9
7/3/2013 11:30:51 AM
More...
|
Lpath, Inc. Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP
5/30/2013 9:18:04 AM
More...
|
Lpath, Inc. Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
5/23/2013 9:40:05 AM
More...
|
Lpath, Inc. Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP
3/22/2013 9:00:37 AM
More...
|
Lpath, Inc. to Present at ROTH Capital Partners 25th Annual Growth Stock Conference on March 19, 2013
3/12/2013 9:13:49 AM
More...
|
Lpath, Inc. Signs Collaboration and License Agreement With Provista Diagnostics (PDx) to Develop Cancer Diagnostics
3/6/2013 9:20:35 AM
More...
|
Lpath, Inc. to Present Data at Arrowhead Conferences's 3rd Annual Traumatic Brain Injury Conference on March 7, 2013
2/25/2013 10:21:29 AM
More...
|
Lpath, Inc. Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
2/13/2013 9:52:06 AM
More...
|
|